心脏代谢指数与PCI后冠状动脉微血管功能障碍在急性STEMI患者之间的关系
Xiang Sha1, Wei Wang1, Jian Wang1
1Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, 225300, People's Republic of China.
Journal of multidisciplinary healthcare
|September 15, 2025
概括
较高的心脏代谢指数 (CMI) 与ST段升高心肌梗塞 (STEMI) 患者的冠状动脉微血管功能障碍 (CMD) 有关. 将CMI集成到随机森林模型中可以改善CMD预测.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 生物统计学 生物统计学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 在穿皮冠状动脉干预 (PCI) 后对ST段升高心肌梗塞 (STEMI) 患者的结果产生负面影响.
- 心脏代谢指数 (CMI) 是脂质和人体参数的复合标记,与心血管风险有关,但其在PCI后心血管疾病中的作用尚不清楚.
研究的目的:
- 调查CMI与PCI接受STEMI患者中CMD发病率之间的关联.
- 用机器学习方法评估CMI对PCI后CMD的预测能力.
主要方法:
- 对702名接受初级PCI和随后的微血管功能评估的STEMI患者进行了回顾性队列研究.
- 根据非侵入性微血管抵抗指数,患者被分为CMD和非CMD组.
- 我们使用了后勤回归,受限立方线分析和机器学习模型 (随机森林,LightGBM,XGboost,K-Nearest Neighbors).
主要成果:
- 在52.1%的患者中存在CMD;较高的CMI三位数 (T2,T3) 与T1相比显著增加了CMD的几率 (aOR分别为2.41和3.40).
- 在CMI和CMD之间观察到非线性关系 (P < 0.001).
- 随机森林模型显示了CMD的最高预测性能 (AUC = 0.772),CMI通过夏普利分析被确定为关键预测因子.
结论:
- 升高的CMI是PCI后STEMI患者中发展CMD的独立风险因素.
- 当被纳入随机森林机器学习模型时,CMD的CMI的预测价值会得到增强.
相关概念视频
Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828
Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890


